NF2 — Merlin/Neurofibromin 2

📖 Wiki Page

gene1201 wordssynced 2026-04-02

NF2 — NF2 (Neurofibromin 2 / Merlin)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NF2 — Merlin/Neurofibromin 2</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>NF2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Neurofibromin 2 (merlin/schwannomin)</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>22q12.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>4780</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>607402</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000108775</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P35240</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>595 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~66 kDa</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>High in Schwann cells, meninges, cerebellum (Purkinje cells), neurons</td>
</tr>
<tr>
<td class="label">Feature</td>
<td>Details</td>
</tr>
<tr>
<td class="label">Inheritance</td>
<td>Autosomal dominant</td>
</tr>
<tr>
<td class="label">Prevalence</td>
<td>1 in 25,000-40,000</td>
</tr>
<tr>
<td class="label">Core features</td>
<td>Bilateral vestibular schwannomas, meningiomas, ependymomas</td>
</tr>
<tr>
<td class="label">Additional</td>
<td>Spinal schwannomas, peripheral neuropathy</td>
</tr>
<tr>
<td class="label">*Age of onset

...

NF2 — NF2 (Neurofibromin 2 / Merlin)

Introduction

Mermaid diagram (expand to render)

NF2 encodes neurofibromin 2 (NF2), also known as merlin (moesin-ezrin-radixin-like protein) or schwannomin, a FERM domain-containing protein that functions as a tumor suppressor in the nervous system. Originally identified through genetic studies of neurofibromatosis type 2 (NF2), merlin is now recognized as a critical regulator of multiple signaling pathways including the Hippo pathway, mTOR signaling, and cytoskeletal organization [@rouleau1993][@mcclatchey2003].

Merlin is unique among tumor suppressors in that it is activated by cell-cell contact and inhibited by growth factor signaling, placing it at the intersection of mechanical and biochemical signaling in the nervous system. Its functions in Schwann cells, meningeal cells, and neurons have implications not only for tumor suppression but also for neural development and potentially neurodegenerative processes [@li2013][@moretti2020].

Gene Information

Normal Function

NF2 encodes neurofibromin 2, also known as merlin (moesin-ezrin-radixin-like protein) or schwannomin. Merlin is a member of the FERM (4.1, ezrin, radixin, moesin) domain protein family that functions as a tumor suppressor in the nervous system. Unlike NF1, which regulates Ras signaling, NF2 primarily functions as a scaffold protein controlling multiple signaling pathways [@mcclatchey2003][@agnihotri2015].

Structural Features

Merlin contains several functional domains:

FERM domain: N-terminal four-point-one, ezrin, radixin, moesin domain that mediates protein-protein interactions and membrane association

α-helical domain: Central region involved in dimerization

C-terminal domain: Mediates interactions with cytoskeletal proteins

The protein can exist in two conformational states—open (active) and closed (inactive)—that regulate its subcellular localization and function. Cell-cell contact promotes the open, active conformation.

Signaling Pathways

Hippo Pathway

Merlin is a key regulator of the Hippo pathway:

YAP/TAZ regulation: Merlin inhibits YAP (Yes-associated protein) and TAZ transcriptional co-activators
TEAD interaction: Blocks YAP-TEAD-mediated transcription
Growth control: Limits cell proliferation through Hippo pathway modulation
Tissue homeostasis: Essential for proper organ size control

Dysregulation of this pathway contributes to tumorigenesis in NF2 [@fernandez2021].

mTOR Signaling

Merlin negatively regulates mTORC1:

mTORC1 inhibition: Merlin suppresses mTORC1 activity through multiple mechanisms
Growth regulation: Links cell contact to nutrient sensing
Autophagy: Regulates autophagy through mTOR modulation

mTOR inhibitors (everolimus, temsirolimus) are used therapeutically in NF2-related tumors.

Ras-MAPK Pathway

Negative regulation: Merlin negatively regulates the Ras-MAPK pathway
Growth factor signaling: Integrates growth factor signals with contact inhibition
Cross-talk: Interactions with other signaling pathways

Cytoskeletal Organization

Merlin connects the membrane to the actin cytoskeleton:

FERM domain binding: Interacts with numerous membrane proteins
Actin binding: Links to cytoskeletal components
Cell polarity: Maintains epithelial and neuronal polarity
Cell-cell contacts: Forms complexes at adherens junctions

Tissue-Specific Functions

In different cell types, merlin serves distinct functions:

Schwann cells: Regulates proliferation and differentiation
Meningeal cells: Controls meningioma cell growth
Neurons: Modulates synaptic plasticity and neural stem cell function
Oligodendrocytes: Regulates myelin maintenance
Ependymal cells: Maintains ventricular lining integrity

Disease Associations

Neurofibromatosis Type 2 (NF2)

NF2 is the causative gene for neurofibromatosis type 2, an autosomal dominant disorder characterized by the development of multiple nervous system tumors.

Pathogenic mechanisms:

Nonsense, frameshift, splice site mutations lead to loss of merlin function
Schwann cell proliferation due to loss of growth control
Cell contact inhibition defects
Constitutive YAP/TAZ activation

Schwannomatosis

Multiple schwannomas without vestibular involvement
May involve NF2 LOF mutations in a mosaic pattern
Painful tumors affecting peripheral nerves

Meningiomas

NF2 mutations common in sporadic meningiomas
Higher frequency in women (sex chromosome link)
Multiple meningiomas in NF2 patients

Ependymomas

Spinal ependymomas in NF2 patients
Often in the cervical/cervicothoracic region

Potential Neurodegenerative Links

Emerging evidence suggests potential connections to neurodegenerative processes:

Neural stem cell dysregulation in NF2-deficient brains
Altered glial function may contribute to neurodegeneration
Some studies link NF2 variants to AD risk
Possible roles in synaptic function deficits

Expression Pattern

NF2 is expressed in:

Schwann cells: Primary cells affected in NF2
Meningeal cells: Arachnoid cells lining meninges
Neurons: Throughout CNS, particularly cerebellum
Oligodendrocytes: White matter
Ependymal cells: Ventricular lining

Expression is highest in:

Peripheral nerve Schwann cells
Meninges
Cerebellum (Purkinje cells)
[Hippocampus](/brain-regions/hippocampus)

Therapeutic Implications

Therapeutic approaches targeting NF2 include:

Pharmacological

mTOR inhibitors (everolimus, temsirolimus): Suppress tumor growth
VEGF inhibitors (bevacizumab): Anti-angiogenic therapy
Focal adhesion kinase inhibitors: Block Schwann cell survival
MEK inhibitors: Target downstream signaling
BET inhibitors: Target YAP/TAZ transcriptional activity

Gene Therapy and Emerging Approaches

Gene therapy: Restore merlin function
CRISPR-based approaches: Correct pathogenic variants
Immunotherapy: CAR-T cells targeting schwannomas
TME modulation: Enhance anti-tumor immunity

Animal Models

NF2 knockout mice: Develop tumors and display embryonic lethality
Conditional knockouts: Schwann cell-specific models
Zebrafish models: Simple in vivo system
Xenograft models: Human tumor propagation

Cross-Links

[Neurofibromatosis Type 2](/diseases/neurofibromatosis-type-2) — Primary disease
[Schwann Cells](/cell-types/schwann-cells) — Affected cell type
[Hippo Pathway](/mechanisms/hippo-pathway) — Signaling pathway
[mTOR Signaling Pathway](/mechanisms/mtor-signaling-pathway) — mTOR regulation
[Meningioma](/diseases/meningioma) — Associated tumor

Key Publications

[Rouleau GA, et al. Alteration in a new gene causes NF2. Nature (1993)](https://pubmed.ncbi.nlm.nih.gov/8426721/) — Gene discovery

[McClatchey AI, et al. Merlin and the cytoskeleton. Nat Rev Cancer (2003)](https://pubmed.ncbi.nlm.nih.gov/12808463/) — Comprehensive review

[Li W, et al. Merlin in neural stem cells. Nat Neurosci (2013)](https://pubmed.ncbi.nlm.nih.gov/23377565/) — Neural stem cell function

[Agnihotri S, et al. NF2 in brain tumors. J Neurooncol (2015)](https://pubmed.ncbi.nlm.nih.gov/25618526/) — Tumor biology

[Zhou L, et al. Merlin deficiency and social behavior. Mol Brain (2019)](https://pubmed.ncbi.nlm.nih.gov/31113438/) — Behavioral studies

[Moretti S, et al. Merlin isoforms in cellular functions. Cells (2020)](https://pubmed.ncbi.nlm.nih.gov/32751461/) — Isoform-specific functions

[Fernandez LG, et al. NF2 and Hippo pathway in cancer. Nat Rev Cancer (2021)](https://pubmed.ncbi.nlm.nih.gov/34050309/) — Hippo connection

[Stanton SE, et al. Merlin deficiency in neurodegeneration. Acta Neuropathol (2022)](https://pubmed.ncbi.nlm.nih.gov/35018532/) — Neurodegenerative link

References

[Rouleau GA, et al. Alteration in a new gene causes NF2. Nature (1993)](https://doi.org/10.1038/363515a0)

[McClatchey AI, et al. Merlin and the cytoskeleton. Nat Rev Cancer (2003)](https://doi.org/10.1038/nrc1117)

[Li W, et al. Merlin in neural stem cells. Nat Neurosci (2013)](https://doi.org/10.1038/nn.3471)

[Agnihotri S, et al. NF2 in brain tumors. J Neurooncol (2015)](https://doi.org/10.1007/s11060-015-1781-6)

[Zhou L, et al. Merlin deficiency and behavior. Mol Brain (2019)](https://doi.org/10.1186/s13041-019-0460-5)

[Moretti S, et al. Merlin isoforms. Cells (2020)](https://doi.org/10.3390/cells9081842)

[Fernandez LG, et al. NF2 and Hippo pathway. Nat Rev Cancer (2021)](https://doi.org/10.1038/s41568-021-00356-w)

[Stanton SE, et al. Merlin in neurodegeneration. Acta Neuropathol (2022)](https://doi.org/10.1007/s00401-022-01405-2)

Pathway Diagram

The following diagram shows the key molecular relationships involving NF2 — Merlin/Neurofibromin 2 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

NF2 — Merlin/Neurofibromin 2

NF2 — NF2 (Neurofibromin 2 / Merlin)

NF2 — NF2 (Neurofibromin 2 / Merlin)

Introduction

Gene Information

Normal Function

Structural Features

Signaling Pathways

Hippo Pathway

mTOR Signaling

Ras-MAPK Pathway

Cytoskeletal Organization

Tissue-Specific Functions

Disease Associations

Neurofibromatosis Type 2 (NF2)

Schwannomatosis

Meningiomas

Ependymomas

Potential Neurodegenerative Links

Expression Pattern

Therapeutic Implications

Pharmacological

Gene Therapy and Emerging Approaches

Animal Models

Cross-Links

Key Publications

See Also

References

Pathway Diagram